Dialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients
- 1 February 2004
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 65 (2) , 682-691
- https://doi.org/10.1111/j.1523-1755.2004.00429.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trialKidney International, 2001
- Mortality Risk by Hemodialyzer Reuse Practice and Dialyzer Membrane Characteristics: Results From the USRDS Dialysis Morbidity and Mortality StudyAmerican Journal of Kidney Diseases, 2001
- Mortality caused by sepsis in patients with end-stage renal disease compared with the general populationKidney International, 2000
- Septicemia in dialysis patients: Incidence, risk factors, and prognosisKidney International, 1999
- Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patientsKidney International, 1998
- Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot StudyKidney International, 1997
- Phagocytosis in uremic and hemodialysis patients: A prospective and cross sectional studyKidney International, 1991
- Evaluation of phagocytic cell function in an ex vivo model of hemodialysisKidney International, 1990
- Polymorphonuclear Leukocyte Function during Hemodialysis: Relationship to Complement ActivationNephron, 1989
- Oxidative Metabolism and Phagocytosis of Polymorphonuclear Leukocytes in Patients with Chronic Renal FailureNephron, 1988